Technical Analysis for REVB - Revelation Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Lizard Bullish | Bullish Day Trade Setup | -2.33% | |
| Doji - Bullish? | Reversal | -2.33% | |
| Lower Bollinger Band Touch | Weakness | -2.33% | |
| Oversold Stochastic | Weakness | -2.33% | |
| Calm After Storm | Range Contraction | -4.73% | |
| NR7 | Range Contraction | -4.73% | |
| Oversold Stochastic | Weakness | -4.73% | |
| MACD Bearish Centerline Cross | Bearish | -9.00% | |
| Calm After Storm | Range Contraction | -9.00% | |
| Stochastic Reached Oversold | Weakness | -9.00% |
| Alert | Time |
|---|---|
| Lizard Bullish Entry | about 1 hour ago |
| Rose Above Previous Day's High | about 1 hour ago |
| Up 3% | about 1 hour ago |
| Down 2 % | about 1 hour ago |
| Down 1% | about 1 hour ago |
Get this analysis on your stocks daily!
- Earnings date: 11/07/2024
Revelation Biosciences, Inc. Description
Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. Revelation has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. In addition to Revelation’s therapeutic pipeline, Revelation is also developing REVDx-501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Disease Immunology Infection Respiratory Diseases Vaccination Allergology Nasal Administration Rhinitis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 25.26 |
| 52 Week Low | 0.702 |
| Average Volume | 634,800 |
| 200-Day Moving Average | 1.76 |
| 50-Day Moving Average | 0.84 |
| 20-Day Moving Average | 0.85 |
| 10-Day Moving Average | 0.86 |
| Average True Range | 0.07 |
| RSI (14) | 40.83 |
| ADX | 15.14 |
| +DI | 20.24 |
| -DI | 22.92 |
| Chandelier Exit (Long, 3 ATRs) | 0.83 |
| Chandelier Exit (Short, 3 ATRs) | 0.94 |
| Upper Bollinger Bands | 0.98 |
| Lower Bollinger Band | 0.73 |
| Percent B (%b) | 0.12 |
| BandWidth | 28.86 |
| MACD Line | -0.02 |
| MACD Signal Line | 0.00 |
| MACD Histogram | -0.0122 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.84 | ||||
| Resistance 3 (R3) | 0.84 | 0.80 | 0.83 | ||
| Resistance 2 (R2) | 0.80 | 0.78 | 0.81 | 0.82 | |
| Resistance 1 (R1) | 0.78 | 0.77 | 0.76 | 0.79 | 0.82 |
| Pivot Point | 0.75 | 0.75 | 0.74 | 0.75 | 0.75 |
| Support 1 (S1) | 0.73 | 0.73 | 0.71 | 0.73 | 0.70 |
| Support 2 (S2) | 0.69 | 0.71 | 0.70 | 0.70 | |
| Support 3 (S3) | 0.67 | 0.69 | 0.69 | ||
| Support 4 (S4) | 0.68 |
